Prospective randomized trial of preoperative enteral immunonutrition followed by elective total gastrectomy for gastric cancer

British Journal of Surgery

Volumn 99, Issue 5, 2012, Pages 621-629

  Fujitani, K ^a   Tsujinaka, T ^a   Fujita, J ^d   Miyashiro, I ^b   Imamura, H ^e   Kimura, Y ^c   Kobayashi, K ^f   Kurokawa, Y ^g   Shimokawa, T ^h   Furukawa, H ^e  

^a OSAKA NATIONAL HOSPITAL   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c 11 40 Hijiyamahonmachi   (Japan)

^d TOYONAKA MUNICIPAL HOSPITAL   (Japan)

^e SAKAI MUNICIPAL HOSPITAL   (Japan)

^f Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

^g OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^h UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTIVE SURGERY; ENTERIC FEEDING; FEMALE; GASTRECTOMY; HUMAN; IMMUNOTHERAPY; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STOMACH TUMOR; SURGICAL INFECTION; TREATMENT OUTCOME;

ADULT; AGED; C-REACTIVE PROTEIN; COMBINED MODALITY THERAPY; ENTERAL NUTRITION; FEMALE; GASTRECTOMY; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; SURGICAL PROCEDURES, ELECTIVE; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 84859611847     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8706     Document Type: Article

References (40)

1. Heys SD, Walker LG, Smith I, Eremin O,. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 1999; 229: 467-477.
2. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U,. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001; 286: 944-953.
3. Montejo JC, Zarazaga A, Lõpez-Martínez J, UrrÃtia G, Roqué M, Blesa AL, et al.,; Spanish Society of Intensive Care Medicine and Coronary Units. Immunonutrition in the intensive care unit. A systematic review and consensus statement. Clin Nutr 2003; 22: 221-233.
4. Zheng Y, Li F, Qi B, Luo B, Sun H, Liu S, et al., Application of perioperative immunonutrition for gastrointestinal surgery: a meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr 2007; 16 (Suppl 1): 253-257.
5. Fritsche K,. Fatty acids as modulators of the immune response. Annu Rev Nutr 2006; 26: 45-73.
6. Senkal M, Zumtobel V, Bauer KH, Marpe B, Wolfram G, Frei A, et al., Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg 1999; 134: 1309-1316.
7. Braga M, Gianotti L, Nespoli L, Radaelli G, Di Carlo V,. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg 2002; 137: 174-180.
8. Tsujinaka T, Hirao M, Fujitani K, Mishima H, Ikenaga M, Sawamura T, et al., Effect of preoperative immunonutrition on body composition in patients undergoing abdominal cancer surgery. Surg Today 2007; 37: 118-121.
9. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, et al., Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345: 745-748.
10. Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, et al.,; for the Surgical Cooperative Group. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 1996; 347: 995-999.
11. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG,. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13: 606-608.
12. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al.,; International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005; 138: 8-13.
13. Mohri Y, Tonouchi H, Kobayashi M, Nakai K, Kusunoki M,; Mie Surgical Infection Research Group. Randomized clinical trial of single- versus multiple-dose antimicrobial prophylaxis in gastric cancer surgery. Br J Surg 2007; 94: 683-688.
14. Uchiyama K, Takifuji K, Tani M, Ueno M, Kawai M, Ozawa S, et al., Prevention of postoperative infections by administration of antimicrobial agents immediately before surgery for patients with gastrointestinal cancers. Hepatogastroenterology 2007; 54: 1487-1493.
15. Suehiro T, Hirashita T, Araki S, Matsumata T, Tsutsumi S, Mochiki E, et al., Prolonged antibiotic prophylaxis longer than 24 hours does not decrease surgical site infection after elective gastric and colorectal surgery. Hepatogastroenterology 2008; 55: 1636-1639.
16. Ozalp N, ZülfikaroÇlu B, GöÃmen E, Acar A, Ekiz I, Koà M, et al., Risk factors for surgical site infection after gastrectomy with D2 lymphadenectomy. Surg Today 2009; 39: 1013-1015.
17. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1998; 1: 10-24.
18. Lobo DN, Williams RN, Welch NT, Aloysius MM, Nunes QM, Padmanabhan J, et al., Early postoperative jejunostomy feeding with an immune modulating diet in patients undergoing resectional surgery for upper gastrointestinal cancer: a prospective, randomized, controlled, double-blind study. Clin Nutr 2006; 25: 716-726.
19. Torosian MH,. Perioperative nutrition support for patients undergoing gastrointestinal surgery: critical analysis and recommendations. World J Surg 1999; 23: 565-569.
20. Klek S, Sierzega M, Szybinski P, Szczepanek K, Scislo L, Walewska E, et al., The immunomodulating enteral nutrition in malnourished surgical patients. A prospective, randomized, double-blind clinical trial. Clin Nutr 2011; 30: 282-288.
21. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 2002; 26 (Suppl): 1SA-138SA.
22. Weimann A, Braga M, Harsanyi L, Laviano A, Ljunggvist O, Soeters P, et al., ESPEN (European Society for Parenteral and Enteral Nutrition). ESPEN Guidelines on Enteral Nutrition: surgery including organ transplantation. Clin Nutr 2006; 25: 224-244.
23. Kudsk KA, Tolley EA, DeWitt RC, Janu PG, Blackwell AP, Yeary S, et al., Preoperative albumin and surgical site identify surgical risk for major postoperative complications. J Parenter Enteral Nutr 2003; 27: 1-9.
24. Kudsk KA,. Immunonutrition in surgery and critical care. Annu Rev Nutr 2006; 26: 463-479.
25. Klek S, Kulig J, Sierzega M, Szybinski P, Szczepanek K, Kubisz A, et al., The impact of immunostimulating nutrition on infectious complications after upper gastrointestinal surgery. A prospective, randomized, clinical trial. Ann Surg 2008; 248: 212-220.
26. Heslin MJ, Latkany L, Leung D, Brooks AD, Hochwald SN, Pisters PW, et al., A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg 1997; 226: 567-577.
27. Daly JM, Lieberman MD, Goldfine J, Shou J, Weintraub F, Rosato EF, et al., Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 1992; 112: 56-67.
28. Daly JM, Weintraub FN, Shou J, Rosato EF, Lucia M,. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 1995; 221: 327-338.
29. Schilling J, Vranjes N, Fierz W, Joller H, Gyurech D, Ludwig E, et al., Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat i.v. solutions. Nutrition 1996; 12: 423-429.
30. Gianotti L, Braga M, Vignali A, Balzano G, Zerbi A, Bisagni P, et al., Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms. Arch Surg 1997; 132: 1222-1229.
31. Senkal M, Mumme A, Eickhoff U, Geier B, Spath G, Wulfert D, et al., Early postoperative enteral immunonutrition: clinical outcome and cost-comparison analysis in surgical patients. Crit Care Med 1997; 25: 1489-1496.
32. Braga M, Gianotti L, Radaelli G, Vignali A, Mari G, Gentilini O, et al., Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double blind phase 3 trial. Arch Surg 1999; 134: 428-433.
33. Kodera Y, Sasako M, Yamamoto S, Sano T, Nashimoto A, Kurita A,; Gastric Cancer Surgery Study Group of Japan Clinical Oncology Group. Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg 2005; 92: 1103-1109.
34. Tsujinaka T, Sasako M, Yamamoto S, Sano T, Kurokawa Y, Nashimoto A, et al.,; Gastric Cancer Surgery Study Group of Japan Clinical Oncology Group. Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501). Ann Surg Oncol 2007; 14: 355-361.
35. Fujitani K, Ajani JA, Crane CH, Feig BW, Pisters PW, Janjan N, et al., Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction. Ann Surg Oncol 2007; 14: 2010-2017.
36. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V,. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 2002; 122: 1763-1770.
37. Braga M, Gianotti L, Vignali A, Carlo VD,. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 2002; 132: 805-814.
38. Braga M, Gianotti L, Vignali A, Di Carlo V,. Immunonutrition in gastric cancer surgical patients. Nutrition 1998; 14: 831-835.
39. Giger U, Büchler M, Farhadi J, Berger D, Hüsler J, Schneider H, et al., Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery - a randomized controlled pilot study. Ann Surg Oncol 2007; 14: 2798-2806.
40. Okamoto Y, Okano K, Izuishi K, Usuki H, Wakabayashi H, Suzuki Y,. Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition. World J Surg 2009; 33: 1815-1821.